Medpace Holdings Inc

16 ott 2026, 20:07 UTC

Medpace Holdings Inc shares are declining, finishing significantly lower since Thursday's close, despite a slight recovery earlier in the session.

15 ott 2026, 20:07 UTC

Medpace Holdings Inc shares advanced during Thursday's session, supported by a maintained Buy rating on Thermo Fisher Scientific Inc and strong user commentary on performance.

14 ott 2026, 20:07 UTC

Medpace Holdings Inc shares are advancing, following an early surge that marked its highest cumulative return, despite some retracement during Wednesday's trading session.

12 ott 2026, 19:56 UTC

Medpace Holdings Inc is trading higher, having gained traction since Friday and currently positioned above its 20-day moving average.

9 ott 2026, 20:06 UTC

Medpace Holdings Inc is advancing, benefiting from broader market gains since Thursday, despite pulling back slightly from an earlier session peak.

8 ott 2026, 21:40 UTC

Medpace Holdings Inc is trading lower in after-market hours, continuing a decline since Thursday's close and indicating ongoing weakness below its 20-day moving average.

6 ott 2026, 20:00 UTC

Medpace Holdings Inc shares fell amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

5 ott 2026, 20:01 UTC

Charles River Laboratories is sharply higher after a positive earnings report, while Medpace Holdings is also advancing, despite earlier pulling back from a session high.

1 ott 2026, 20:02 UTC

Medpace Holdings Inc shares fell amid a broader market decline, reversing the recent trend of higher daily closes since Wednesday's close.

30 set 2026, 19:35 UTC

UBS upgraded Medpace Holdings Inc to Neutral with a price target of $673, as shares trade higher amid strong historical performance despite recent insider selling.

25 set 2026, 20:07 UTC

Medpace Holdings Inc shares fell, reflecting a decline from Thursday's close, amid sympathy with Thermo Fisher Scientific Inc, which is also down.

24 set 2026, 20:07 UTC

Medpace shares are modestly higher as President and CEO August J. Troendle sold 70.9k shares for about $44.43 million, following strong revenue growth.

23 set 2026, 20:01 UTC

Medpace Holdings Inc shares fell sharply on Wednesday, aligning with a decline in Charles River Laboratories, despite remaining above its 20-day moving average.

22 set 2026, 23:01 UTC

Medpace Holdings Inc is rising in after-market trading, continuing a trend above its 20-day moving average and closing higher for three consecutive sessions.

15 set 2026, 20:01 UTC

Medpace Holdings Inc. is trading higher today despite negative broader market sentiment following a significant drop in the NY Empire State Manufacturing Index.

11 set 2026, 20:08 UTC

Medpace Holdings Inc. is advancing during Friday's session, having reached a session high earlier, though it has since pulled back from that peak.

3 set 2026, 20:07 UTC

Medpace Holdings shares are declining amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2 set 2026, 20:08 UTC

Medpace Holdings Inc. is rising amid broader gains in the Life Sciences Tools & Services sector, despite no specific company news driving the movement.

1 set 2026, 20:08 UTC

Medpace Holdings Inc shares are lower amid insider selling and an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing.

31 ago 2026, 20:07 UTC

Medpace Holdings shares are lower today, reflecting broader sector dynamics and rising interest rate expectations following the Jackson Hole Economic Symposium.

26 ago 2026, 20:08 UTC

Medpace Holdings Inc. shares are higher today, continuing an upward trend since Tuesday's close. The stock remains above its 20-day moving average.

25 ago 2026, 20:07 UTC

Shares of Medpace Holdings Inc are trading lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing by company officers.

20 ago 2026, 19:41 UTC

Medpace Holdings Inc. is rising amid strong gains in the Life Sciences Tools & Services sector and positive sentiment surrounding biotech investments.

19 ago 2026, 20:02 UTC

Medpace Holdings Inc. shares are higher, driven by a significant advance in the Life Sciences Tools & Services sub-sector amid a strong market session.

17 ago 2026, 20:02 UTC

Medpace Holdings Inc. shares are higher following a Barron's report suggesting significant upside potential and robust Q2 results exceeding analyst expectations.

14 ago 2026, 19:36 UTC

Medpace Holdings Inc shares are lower amid broader market sentiment following a Commerce Department report showing a decline in retail sales for July.

13 ago 2026, 19:56 UTC

Medpace Holdings shares are lower as CEO August J. Troendle sold 23,144 shares valued at $13.98 million, raising investor concerns about future performance.

7 ago 2026, 19:16 UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

3 ago 2026, 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

30 lug 2026, 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.